These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 29665800

  • 1. MDA-5 associated rapidly progressive interstitial lung disease with recurrent Pneumothoraces: a case report.
    Alqatari S, Riddell P, Harney S, Henry M, Murphy G.
    BMC Pulm Med; 2018 Apr 17; 18(1):59. PubMed ID: 29665800
    [Abstract] [Full Text] [Related]

  • 2. Adolescent-onset anti-MDA5 antibody-positive juvenile dermatomyositis with rapidly progressive interstitial lung disease and spontaneous pneumomediastinum: a case report and literature review.
    Yeung TW, Cheong KN, Lau YL, Tse KN.
    Pediatr Rheumatol Online J; 2021 Jun 30; 19(1):103. PubMed ID: 34193210
    [Abstract] [Full Text] [Related]

  • 3. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
    Nishi K, Ogura M, Tamai N, Gima M, Ide K, Koinuma G, Kamei K, Ito S.
    Pediatr Rheumatol Online J; 2022 Aug 04; 20(1):60. PubMed ID: 35927666
    [Abstract] [Full Text] [Related]

  • 4. [Dermatomyositis and acute interstitial lung disease associated with MDA-5 antibodies: an atypical case].
    Girard C, Vincent T, Bessis D.
    Ann Dermatol Venereol; 2013 Oct 04; 140(10):628-34. PubMed ID: 24090894
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Fatal outcome of anti-MDA5 juvenile dermatomyositis in a paediatric COVID-19 patient: a case report.
    Quintana-Ortega C, Remesal A, Ruiz de Valbuena M, de la Serna O, Laplaza-González M, Álvarez-Rojas E, Udaondo C, Alcobendas R, Murias S.
    Mod Rheumatol Case Rep; 2021 Jan 04; 5(1):101-107. PubMed ID: 33019894
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A case of anti-MDA5-positive rapidly progressive interstitial lung disease in a patient with clinically amyopathic dermatomyositis ameliorated by rituximab, in addition to standard immunosuppressive treatment.
    Koichi Y, Aya Y, Megumi U, Shunichi K, Masafumi S, Hiroaki M, Masahiko K, Shinsuke K, Manabu U, Kenichiro H, Fumiaki A, Nozomi A, Toshitaka M, Masayoshi Y, Chikako K, Yoshinao M, Tatsuo S, Masahiko K.
    Mod Rheumatol; 2017 May 04; 27(3):536-540. PubMed ID: 25698373
    [Abstract] [Full Text] [Related]

  • 10. Anti-SAE autoantibody-positive Japanese patient with juvenile dermatomyositis complicated with interstitial lung disease - a case report.
    Kishi T, Tani Y, Okiyama N, Mizuochi K, Ichimura Y, Harigai M, Nagata S, Miyamae T.
    Pediatr Rheumatol Online J; 2021 Mar 19; 19(1):34. PubMed ID: 33740993
    [Abstract] [Full Text] [Related]

  • 11. Differential clinical features of patients with clinically amyopathic dermatomyositis who have circulating anti-MDA5 autoantibodies with or without myositis-associated autoantibodies.
    Yamaguchi K, Yamaguchi A, Kashiwagi C, Sawada Y, Taguchi K, Umetsu K, Oshima K, Uchida M, Suzuki M, Kono S, Takemura M, Masubuchi H, Kitahara S, Hara K, Maeno T, Motegi SI, Muro Y, Sakairi T, Hisada T, Kurabayashi M.
    Respir Med; 2018 Jul 19; 140():1-5. PubMed ID: 29957268
    [Abstract] [Full Text] [Related]

  • 12. [Dermatomyositis associated with anti-MDA5 autoantibody].
    Collado MV, Gargiulo MLÁ, Gómez R, Gómez G, Pérez N, Suarez L, Taratuto AL, Aruj P.
    Medicina (B Aires); 2018 Jul 19; 78(5):360-363. PubMed ID: 30285929
    [Abstract] [Full Text] [Related]

  • 13. New-onset dermatomyositis following COVID-19: A case report.
    Shimizu H, Matsumoto H, Sasajima T, Suzuki T, Okubo Y, Fujita Y, Temmoku J, Yoshida S, Asano T, Ohira H, Ejiri Y, Migita K.
    Front Immunol; 2022 Jul 19; 13():1002329. PubMed ID: 36353621
    [Abstract] [Full Text] [Related]

  • 14. [Three cases report of juvenile dermatomyositis with positive anti-melanoma differentiation associated gene 5 (MDA5) antibody and severe interstitial lung disease and literature review].
    Hou J, Zhou ZX, Li JG, Xu YJ, Ding YC.
    Zhonghua Er Ke Za Zhi; 2019 Dec 02; 57(12):928-933. PubMed ID: 31795559
    [Abstract] [Full Text] [Related]

  • 15. A 65-year-old Woman With Persistent Dyspnea, Arthritis, and Raynaud's Phenomenon.
    Chong WH, Saha BK, Beegle S.
    Am J Med Sci; 2021 Apr 02; 361(4):526-533. PubMed ID: 33386120
    [Abstract] [Full Text] [Related]

  • 16. Anti-MDA5 antibody-positive hypomyopathic dermatomyositis complicated with pneumomediastinum.
    Yashiro M, Asano T, Sato S, Kobayashi H, Watanabe H, Miyata M, Migita K.
    Fukushima J Med Sci; 2018 Apr 02; 64(2):89-94. PubMed ID: 30158335
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Progressive, refractory macrophage activation syndrome as the initial presentation of anti-MDA5 antibody positive juvenile dermatomyositis: a case report and literature review.
    Stewart JA, Price T, Moser S, Mullikin D, Bryan A.
    Pediatr Rheumatol Online J; 2022 Feb 22; 20(1):16. PubMed ID: 35193600
    [Abstract] [Full Text] [Related]

  • 19. Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
    Ikeda S, Arita M, Morita M, Ikeo S, Ito A, Tokioka F, Noyama M, Misaki K, Notohara K, Ishida T.
    BMC Pulm Med; 2015 Dec 09; 15():159. PubMed ID: 26651481
    [Abstract] [Full Text] [Related]

  • 20. Erythroderma and extensive poikiloderma - a rare initial presentation of dermatomyositis: a case report.
    Herath HMMTB, Keragala BSDP, Pahalagamage SP, Janappriya GHCC, Kulatunga A, Gunasekera CN.
    J Med Case Rep; 2018 Mar 24; 12(1):83. PubMed ID: 29571300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.